Coombes RC - Search Results

1

Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.

Evans TR, Di Salle E, Ornati G, Lassus M, Benedetti MS, Pianezzola E, Coombes RC. Evans TR, et al. Among authors: coombes rc. Cancer Res. 1992 Nov 1;52(21):5933-9. Cancer Res. 1992. PMID: 1394219 Clinical Trial.

2

Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.

Dowsett M, Stein RC, Coombes RC. Dowsett M, et al. Among authors: coombes rc. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):155-9. doi: 10.1016/0960-0760(92)90201-s. J Steroid Biochem Mol Biol. 1992. PMID: 1388047 Review.

3

A preliminary clinical study of gossypol in advanced human cancer.

Stein RC, Joseph AE, Matlin SA, Cunningham DC, Ford HT, Coombes RC. Stein RC, et al. Among authors: coombes rc. Cancer Chemother Pharmacol. 1992;30(6):480-2. doi: 10.1007/BF00685601. Cancer Chemother Pharmacol. 1992. PMID: 1394805 Clinical Trial.

4

4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer.

Coombes RC, Hughes SW, Dowsett M. Coombes RC, et al. Eur J Cancer. 1992;28A(12):1941-5. doi: 10.1016/0959-8049(92)90232-q. Eur J Cancer. 1992. PMID: 1419285 Clinical Trial.

5

Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial.

Stein RC, Bower M, Law M, Bliss JM, Barton C, Gazet JC, Ford HT, Coombes RC. Stein RC, et al. Among authors: coombes rc. Eur J Cancer. 1992;28A(12):1963-5. doi: 10.1016/0959-8049(92)90237-v. Eur J Cancer. 1992. PMID: 1419290 Clinical Trial.

6

A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours.

Bower M, Stein R, Evans TR, Hedley A, Pert P, Coombes RC. Bower M, et al. Among authors: coombes rc. Eur J Cancer. 1992;28A(4-5):888-9. doi: 10.1016/0959-8049(92)90142-o. Eur J Cancer. 1992. PMID: 1524917 Clinical Trial.

7

Exemestane (FCE 24304), a new steroidal aromatase inhibitor.

di Salle E, Ornati G, Giudici D, Lassus M, Evans TR, Coombes RC. di Salle E, et al. Among authors: coombes rc. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):137-43. doi: 10.1016/0960-0760(92)90198-r. J Steroid Biochem Mol Biol. 1992. PMID: 1525055 Review.

8

4-Hydroxyandrostenedione treatment for postmenopausal patients with breast cancer.

Coombes RC. Coombes RC. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):145-8. doi: 10.1016/0960-0760(92)90199-s. J Steroid Biochem Mol Biol. 1992. PMID: 1525056

9

An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients.

Dowsett M, Mehta A, King N, Smith IE, Powles TJ, Stein RC, Coombes RC. Dowsett M, et al. Among authors: coombes rc. Eur J Cancer. 1992;28(2-3):415-20. doi: 10.1016/s0959-8049(05)80065-6. Eur J Cancer. 1992. PMID: 1591054 Clinical Trial.

10

Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer.

Davies JH, Dowsett M, Jacobs S, Coombes RC, Hedley A, Shearer RJ. Davies JH, et al. Among authors: coombes rc. Br J Cancer. 1992 Jul;66(1):139-42. doi: 10.1038/bjc.1992.231. Br J Cancer. 1992. PMID: 1637664 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

551 results

Search Page

Filters